Table 2. – Biochemical values and echocardiographic parameters of the study population.
| Dipper group n=46 | Non-dipper group n=95 | p | |
|---|---|---|---|
| Peak hs-troponin I (ng/L) * | 2413 (13.9-50000) | 9036 (1.01-150050) | 0.021c |
| Creatinine (mg/dL) * | 0.94 (0.56-1.66) | 0.87 (0.63-1.86) | 0.361c |
| eGFR (ml/dk/1,73 m2) * | 83.5 (34-114) | 89.6 (32.9-118) | 0.737c |
| Sodium (mmol/L) | 137±2 | 137±2 | 0.549a |
| Potassium (mmol/L) | 4.3±0.3 | 4.3±0.4 | 0.930a |
| Calcium (mg/dL) | 9.0±0.4 | 8.8±0.5 | 0.058a |
| ALT (IU/L) * | 24 (9-94) | 24 (6-150) | 0.418c |
| AST (IU/L) * | 35.5 (15-291) | 38 (10-472) | 0.809c |
| CRP (mg/L) * | 2.65 (0-79) | 2.4 (0-93) | 0.974c |
| FBG (mg/dL) * | 122.5 (74-367) | 127 (59-316) | 0.427c |
| LDL-C (mg/dL) | 137±39 | 134±39 | 0.709a |
| HDL-C (mg/dL) | 48±18 | 45±12 | 0.301a |
| TC (mg/dL) | 204±48 | 203±43 | 0.880a |
| TG (mg/dL) | 174±143 | 166±147 | 0.541a |
| LV-EDD (mm) | 46.1±4.4 | 47.9±4.6 | 0.037a |
| LV-ESD (mm) | 30.9±5.8 | 33.3±5.6 | 0.025a |
| IVS (mm) * | 11 (8-14) | 12 (9-15) | 0.000c |
| PW (mm) * | 11 (8-14) | 11 (9-14) | 0.045c |
| LA (mm) * | 36 (24-47) | 36 (30-57) | 0.286c |
| EF (%)* | 55 (35-65) | 55 (25-65) | 0.009c |
| DD (n, %) | 31 (67) | 62 (65) | 0.669b |
a Independent t test, b Chi-square test, c Mann–Whitney U test * Data are expressed as median (interquartile range) for continuous variables. ALT: alanine aminotransferase; AST: aspartate aminotransferase; CRP: C-reactive protein; DD: diastolic dysfunction; EF: ejection fraction; eGFR: estimated glomerular filtration rate; FBG: fasting blood glucose; HDL-C: high-density lipoprotein cholesterol; hs-troponin I: high-sensitivity troponin I; IVS: interventricular septum; LA: left atrium; LDL-C: low-density lipoprotein cholesterol; LV-EDD: left ventricular end-diastolic diameter; LV-ESD: left ventricular end-systolic diameter; PW: posterior wall; TC: total cholesterol; TG: triglycerides.